CIRCA: CIRCA STRENGTHENS EUROPEAN TEAM BY RECRUITMENT OF NEXT CEO
Oslo, Norway - 9 May 2023 - As part of the continuous process to strengthen the
organisation for the ongoing industrialisation and growth of Circa, the board of
directors is pleased to announce that Dr. Steve Döring has been appointed as the
next CEO of Circa Group AS. The engagement of Dr. Döring is part of a succession
plan following Tony Duncan's enormous efforts in the CEO role for Circa in over
a decade. Tony Duncan will continue in the CEO role up to the transition with Dr
Döring which is scheduled to take place early in Q4 2023.
Dr. Döring is currently CEO of inprotec AG based in the Southwest of Germany.
inprotec AG is in the chemicals industry known as one of the most experienced
and competent partner for industrial contract manufacturing and contract drying
focusing on the homecare and feed additive markets. inprotec AG employs
approximately 280 employees with an annual revenue of over EUR 60 million. Prior
to this, Dr. Döring was CEO of Leuna Tenside GmbH, a German based chemical
company which is focused on the production and distribution of specialty
surfactants and chlorinated paraffins for various applications. In both of Dr.
Döring's last engagements, the companies have been private equity owned and Dr.
Döring has led the companies through development, scale-up and exit processes.
Dr. Döring started his career in the chemical industry over 20 year ago at
Henkel AG in Düsseldorf in the R&D department before he moved over different
roles and responsibilities in Europe and Asia, including a role as the head of
new business development with Cognis group. In total, he has spent almost 10
years in large multinational companies before he moved into senior business
roles with smaller chemical industry companies.
"I am very pleased to announce Dr. Steve Döring as the next CEO of Circa. Steve
has extensive experience from the chemical industry and more than 10 years in
CEO positions with different chemical companies where he has successfully
delivered on transformation and growth processes. In addition, Dr. Döring has
extensive chemicals knowledge from his background with a PhD in Chemistry and
prior work experience with R&D and business development from among other Henkel
AG and Cognis," says chairman of Circa Group AS Lars P. Sørvaag Sperre.
"I am grateful for the opportunity to join Circa and be part of the team that
will bring sustainable bio chemicals at scale to the chemicals industry and
markets, such as Circa's Cyrene solvent. I am very motivated and excited to take
on the role of CEO later this year, leading the Circa team forward in realising
the great opportunities in its patented Furacell process and its bio chemicals
portfolio. The chemicals industry has to become more sustainable to realise the
green shift, and I very much look forward to contribute in bringing forward a
solution together with the rest of the team at Circa," says Dr. Steve Döring.
Dr. Döring succeeds Tony Duncan who is co-founder of Circa and has been serving
as CEO since 2006. During his time as CEO, Circa has developed from an
Australian development initiative into a well-established, Euronext Growth
listed, renewable chemicals company with a well-known brand internationally and
strong growth ambitions. Following the hand-over of the CEO role, Circa will
propose to the shareholders to elect Tony Duncan to the board of directors of
Circa to continue his engagement for the development of the company.
"I would like to thank Tony Duncan for the enormous efforts and engagement that
has been invested by him to develop Circa from an idea to a company with global
reach and significant growth opportunities. Tony has been instrumental in taking
Circa forward and expanding Circa's footprint in the international chemicals
industry in so many ways, most recently exemplified by the successful opening of
the Circa Renewables Chemicals Institute at the University of York. We are
grateful for Tony's purpose driven effort to develop Circa and look forward to
his continued engagement with Circa after the CEO transition," says chairman of
Circa Group AS Lars P. Sørvaag Sperre.
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM. By creating renewable chemicals from cellulose, Circa is
extracting value from non-food, surplus biomass and contributing to industry as
it transitions to a more circular and decarbonised economy. Circa Group is
listed on the Euronext Growth Market in Oslo, stock symbol CIRCA.
Investor Contact Circa Group
Tone Leivestad, Chief Financial Officer
Circa Group AS
Tel: +47 406 39 455